GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Receivables Turnover

TAK (Takeda Pharmaceutical Co) Receivables Turnover : 1.70 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Takeda Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was $8,227 Mil. Takeda Pharmaceutical Co's average Accounts Receivable for the three months ended in Sep. 2024 was $4,843 Mil. Hence, Takeda Pharmaceutical Co's Receivables Turnover for the three months ended in Sep. 2024 was 1.70.


Takeda Pharmaceutical Co Receivables Turnover Historical Data

The historical data trend for Takeda Pharmaceutical Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Receivables Turnover Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.73 4.23 4.55 5.46 5.78

Takeda Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 1.53 1.44 1.60 1.70

Competitive Comparison of Takeda Pharmaceutical Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Receivables Turnover falls into.



Takeda Pharmaceutical Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Takeda Pharmaceutical Co's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Receivables Turnover (A: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2024 ) / ((Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count )
=28459.497 / ((5047.653 + 4796.968) / 2 )
=28459.497 / 4922.3105
=5.78

Takeda Pharmaceutical Co's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

Receivables Turnover (Q: Sep. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2024 ) / ((Accounts Receivable (Q: Jun. 2024 ) + Accounts Receivable (Q: Sep. 2024 )) / count )
=8226.688 / ((4785.411 + 4900.437) / 2 )
=8226.688 / 4842.924
=1.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co  (NYSE:TAK) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Takeda Pharmaceutical Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.